1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with hydantoins in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JH; Hien, TT; Kang, KW; Kim, S; Kim, YC; Kim, YG; Ko, H; Lee, GE; Lee, SD; Lim, SC; Park, JH; Yang, JW | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and hydantoins
| Article | Year |
|---|---|
Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arthritis, Experimental; Carrageenan; Cattle; Collagen Type II; Drug Discovery; Edema; Enzyme-Linked Immunosorbent Assay; HEK293 Cells; Humans; Hydantoins; Immunoblotting; Inflammation; Interleukin-1beta; Long-Term Potentiation; Macrophages; Male; Mice, Inbred DBA; Molecular Structure; Monocytes; Neuralgia; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Structure-Activity Relationship; Sulfonic Acids; Tissue Distribution | 2015 |